Total Revenue Increases 40% Year over Year
MINDBODY, Inc. (NASDAQ:MB), the leading technology platform for the
fitness, beauty and wellness services industries, today announced
financial results for the second quarter ended June 30, 2018.
“Q2 marks our first quarter post-Booker
acquisition, and we are pleased to report strong operating results
and progress on integration of the two companies,” said Rick
Stollmeyer, co-founder and chief executive officer of MINDBODY.
“With more fitness, beauty and wellness businesses on our platform
than ever before, and the best go-to-market team in the industry,
we have taken a substantial step towards our purpose of helping
hundreds of millions of people live healthier, happier lives.”
"We delivered strong revenue growth in the
second quarter, driven by the continued shift of our subscriber
base into higher priced software tiers," said Brett White, chief
operating officer and chief financial officer. "These customers
drive our business as they deliver the vast majority of GMV and
payments volume.”
Second Quarter 2018 Financial
Results
- Total revenue for the second quarter of 2018 was $61.6 million,
a 40% increase year over year.
- Subscription and services revenue for the second quarter of
2018 was $38.5 million, a 48% increase year over year.
- Payments revenue for the second quarter of 2018 was $22.3
million, a 26% increase year over year.
- GAAP net loss for the second quarter of 2018 was $(16.9)
million, or $(0.36) per share, compared to a GAAP net loss for the
second quarter of 2017 of $(4.4) million, or $(0.10) per
share.
- Non-GAAP net loss1 for the second quarter of 2018 was $(2.9)
million, or $(0.06) per share, compared to a non-GAAP net loss for
the second quarter of 2017 of $(0.5) million, or $(0.01) per
share.
- Adjusted EBITDA1 for the second quarter of 2018 was $(0.5)
million, compared to Adjusted EBITDA for the second quarter of 2017
of $1.7 million.
Recent Business Highlights
- Raised net proceeds of approximately $265 million in
convertible senior notes, enabling us to invest in growth with
flexibility to pursue opportunistic M&A.
- Partnered with the nonprofit Partnership for a Healthier
America (PHA) with their Healthier Campus Initiative, helping young
adults more easily engage with fitness and wellness
activities.
- Experienced strong early adoption of FitMetrix and Frederick,
which we acquired in the first half of the year.
Second Quarter Key Metrics
We regularly review the following key metrics to
measure our performance, identify trends affecting our business,
formulate financial projections, make strategic business decisions
and assess working capital needs.
|
As of and for the Quarter Ended
June 30, |
2018 |
|
2017 |
|
YoY |
Subscribers
(end of period)2 |
68,142 |
|
|
59,345 |
|
|
15 |
% |
Average
monthly revenue per subscriber |
$ |
293 |
|
|
$ |
244 |
|
|
20 |
% |
Payments
volume (in millions) |
$ |
2,716 |
|
|
$ |
1,950 |
|
|
39 |
% |
Dollar-based net expansion rate (average for the quarter)3 |
103 |
% |
|
108 |
% |
|
|
1 A reconciliation of GAAP to non-GAAP
financial measures is provided in the financial statement tables
included in this press release. An explanation of these measures is
also included under the heading “Non-GAAP Financial
Measures.”2 We define subscribers as unique physical locations
or individual practitioners who have active subscriptions to our
services, including MINDBODY, Booker or FitMetrix, as of the end of
the period. Subscribers do not include locations or practitioners
who only use Frederick (our marketing automation
software.)3 Starting the first quarter of 2018, we calculate
our dollar-based net expansion rate using a quarterly average. We
believe that this change in methodology for calculating our
dollar-based net expansion rate mitigates some of the volatility
that can occur when this key metric is calculated using only the
last month in the period. Prior periods have been adjusted to
conform with this new methodology.
Outlook
For the third quarter and full year 2018,
MINDBODY expects to report:
- Revenue for the third quarter of 2018 in the range of $63.0
million to $65.0 million, representing 35% to 39% growth over the
third quarter of 2017.
- Revenue for the full year of 2018 in the range of $246.0
million to $250.0 million, representing 35% to 37% growth over the
full year of 2017.
- Non-GAAP net loss for the third quarter of 2018 in the range of
$(4.0) million to $(2.5) million and weighted average shares
outstanding for the third quarter of approximately 47.9 million
shares.
- Non-GAAP net loss for the full year of 2018 in the range of
$(7.5) million to $(4.5) million and weighted average shares
outstanding for the full year of approximately 47.7 million
shares.
The outlook has been updated to reflect the
acquisitions of FitMetrix and Booker. Non-GAAP net loss excludes
estimates for, among other things, stock-based compensation
expense, amortization of acquired intangible assets,
acquisition-related expenses, including transaction and integration
expenses, and the amortization of debt discount and issuance costs
from our convertible notes. A reconciliation of these non-GAAP
financial guidance measures to corresponding GAAP financial
guidance measures is not available on a forward-looking basis
because we do not provide guidance on GAAP net loss and are not
able to present the various reconciling cash and non-cash items
between GAAP net loss and non-GAAP net loss without unreasonable
effort. In particular, stock-based compensation expense is impacted
by MINDBODY’s future hiring and retention needs, as well as the
future fair market value of MINDBODY’s Class A common stock, all of
which is difficult to predict and is subject to constant
change. The actual amount of these expenses during 2018 will
have a significant impact on MINDBODY’s future GAAP financial
results.
Quarterly Conference Call and Related
Information
MINDBODY will discuss its quarterly results
today at 1:30 p.m. PT (4:30 p.m. ET)
- Dial in: To access the call, please dial (844)
494-0191, or outside the U.S. (508) 637-5581, with Conference ID#
1861529 at least five minutes prior to the 1:30 p.m. PT start
time.
- Webcast and Related Investor Materials: A live
webcast and replay of the call, as well as related investor
materials, will be available at
http://investors.mindbodyonline.com/ under the Events and
Presentations menu.
- Audio replay: An audio replay will be
available between 4:30 p.m. PT July 31, 2018 and 7:30 p.m. PT
August 7, 2018 by calling (855) 859-2056 or (404) 537-3406 with
Passcode 1861529. The replay will also be available at
investors.mindbodyonline.com.
About MINDBODYMINDBODY,
Inc. (NASDAQ:MB) is the leading technology platform for the
fitness, beauty and wellness services industries. Local
entrepreneurs worldwide use MINDBODY's integrated
software and payments platform to run, market and build their
businesses. Consumers use MINDBODY to more easily find,
engage and transact with fitness, wellness and beauty providers in
their local communities. For more information on
how MINDBODY is helping people lead healthier, happier
lives by connecting the world to fitness, beauty and wellness,
visit mindbodyonline.com.
© 2018 MINDBODY, Inc. All rights reserved.
MINDBODY, FitMetrix, Frederick, the Enso logo, the Booker logo and
Connecting the World to Wellness are trademarks or registered
trademarks of MINDBODY Inc. in the United States and/or other
countries. Other company and product names may be trademarks of the
respective companies with which they are associated.
Forward Looking Statements
This press release and the accompanying
conference call contain forward-looking statements including, among
others, current estimates of third quarter and full year 2018
revenue, non-GAAP net loss and weighted average shares outstanding,
and statements relating to our expectations for our recent
acquisitions of FitMetrix and Booker (including its Frederick
technology).
These forward-looking statements involve risks
and uncertainties. If any of these risks or uncertainties
materialize, or if any of our assumptions prove incorrect, our
actual results could differ materially from the results expressed
or implied by these forward-looking statements. These risks and
uncertainties include risks associated with: continued market
acceptance of our platform; engagement of our customers and
consumers; our ability to continue to successfully introduce new
products and enhance our existing products to meet the needs of our
customers and consumers; the return on our strategic investments;
our ability to successfully integrate Booker and FitMetrix; our
ability to achieve expected synergies and efficiencies of
operations between MINDBODY and Booker and FitMetrix; our ability
to realize the market opportunities provided by our acquisitions of
Booker and FitMetrix; our ability to successfully integrate and
maintain Booker's and FitMetrix’s respective technology, products
and personnel; our ability to timely develop and achieve an
effective go-to-market strategy of our combined services; the
impact on the business of Booker and FitMetrix as a result of the
acquisitions, including any loss of Booker or FitMetrix customers
or key employees; execution of our plans and strategies, including
with respect to consumer development, pricing, dynamic pricing,
mobile products and features and MINDBODY Promote; any failure of
our security measures, including the risk that such measures may be
insufficient to secure our customer and consumer data adequately or
that we may become subject to attacks that degrade or deny the
ability of our customers and consumers to access our platform; our
ability to grow and develop our payment processing activities; our
ability to timely and effectively scale and adapt our existing
technology and network infrastructure to ensure that our solutions
are accessible at all times with short or no perceptible load
times; our ability to maintain our rate of revenue growth and
manage our expenses and investment plans; any decrease in customer
demand for our software products, features and/or service
offerings; changes in privacy or other regulations that could
impact our ability to serve our customers and consumers or
adversely impact our monetization efforts; increasing competition;
our ability to manage our growth, including internationally; our
ability to recruit and retain employees; general economic, market
and business conditions; and the risks described in the other
filings we make with the Securities and Exchange Commission from
time to time, including the risks described under the heading “Risk
Factors” in our Annual Report on Form 10-K, which was filed with
the Securities and Exchange Commission on March 1, 2018 and the
risks described under the heading “Risk Factors” in our subsequent
Quarterly Reports on Form 10-Q, which should be read in conjunction
with our financial results and forward-looking statements and are
available on the SEC Filings section of the Investor Relations page
of our website at investors.mindbodyonline.com/.
All forward-looking statements in this press
release are based on information available to us as of the date
hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
Disclosure Information
MINDBODY uses the investor relations section on its website as
the means of complying with its disclosure obligations under
Regulation FD. Accordingly, we recommend that investors should
monitor MINDBODY’s investor relations website in addition to
following MINDBODY’s press releases, SEC filings, and public
conference calls and webcasts.
Non-GAAP Financial Measures
In this press release, MINDBODY has provided
financial information that has not been prepared in accordance with
generally accepted accounting principles in the United States
(GAAP). We disclose the following historical non-GAAP financial
measures in this press release: Adjusted EBITDA, non-GAAP net
income (loss), and non-GAAP net income (loss) per share. We use
these non-GAAP financial measures internally in analyzing our
financial results and evaluating our ongoing operational
performance. We believe that these non-GAAP financial measures
provide an additional tool for investors to use in understanding
and evaluating ongoing operating results and trends in the same
manner as our management and board of directors. Our use of
these non-GAAP financial measures has limitations as an analytical
tool, and you should not consider them in isolation or as a
substitute for analysis of our financial results as reported under
GAAP. Because of these and other limitations, you should
consider these non-GAAP financial measures along with other
GAAP-based financial performance measures, including various cash
flow metrics, net loss, and our GAAP financial results. We have
provided a reconciliation of these non-GAAP financial measures to
their most directly comparable GAAP measures in the financial
statement tables included in this press release, and investors are
encouraged to review the reconciliation.
Adjusted EBITDA
We define Adjusted EBITDA as our GAAP net loss
before (1) stock-based compensation expense, (2) depreciation and
amortization, (3) acquisition-related expenses, including,
transaction and integration expenses, (4) income tax provision
(benefit), and (5) other expense, net, which consisted of interest
income, interest expense, and other income (expense),
net. Prior period acquisition-related expenses were
insignificant. Accordingly, prior periods have not been
adjusted to exclude these expenses.
We have provided below a reconciliation of
Adjusted EBITDA to net loss, the most directly comparable GAAP
financial measure. We have presented Adjusted EBITDA in this
press release because it is a key measure used by our management
and board of directors to understand and evaluate our core
operating performance and trends, to prepare and approve our annual
budget, and to develop short and long-term operational plans. In
particular, we believe that the exclusion of the amounts eliminated
in calculating Adjusted EBITDA can provide a useful measure for
period-to-period comparisons of our core business. Adjusted EBITDA
has a number of limitations, including the following: (1) Adjusted
EBITDA excludes stock-based compensation expense, which has been
and will continue to be for the foreseeable future a significant
recurring expense in MINDBODY’s business; (2) although depreciation
and amortization expense are non-cash charges, the assets being
depreciated and amortized may have to be replaced in the future,
and Adjusted EBITDA does not reflect cash capital expenditure
requirements for such replacements or for new capital expenditure
requirements; (3) Adjusted EBITDA does not reflect the cash
requirements for acquisition-related expenses or tax payments; and
(4) other companies, including companies in our industry, may
calculate Adjusted EBITDA or similarly titled measures differently,
which reduces its usefulness as a comparative measure.
Non-GAAP net income (loss) and non-GAAP
net income (loss) per share
We define non-GAAP net income (loss) as GAAP net
income (loss) attributable to common stockholders before: (1)
stock-based compensation expense, (2) amortization of acquired
intangible assets, (3) acquisition-related expenses, including
transaction and integration expenses, (4) partial releases of
valuation allowances due to acquisition, and (5) the amortization
of debt discount and issuance costs from our convertible notes.
Non-GAAP net income per share is calculated as non-GAAP net income
divided by the diluted weighted-average shares outstanding.
Non-GAAP net loss per share, is calculated as non-GAAP net loss
divided by the weighted-average shares outstanding. Prior period
acquisition-related expenses were insignificant. Accordingly, prior
periods have not been adjusted to exclude these expenses.
These non-GAAP financial measures have a number
of limitations, including the following: (1) these non-GAAP
financial measures exclude stock-based compensation expense and the
amortization of debt discount and issuance costs from our
convertible notes, which has been and will continue to be for the
foreseeable future a significant recurring expense in MINDBODY’s
business; and (2) other companies, including companies in our
industry, may exclude different items in their calculation of these
non-GAAP financial measures, which reduces their usefulness as a
comparative measure.
MINDBODY,
INC.Condensed Consolidated Balance
Sheets(in thousands, except share and per share
data)(Unaudited) |
|
|
|
|
|
|
|
June 30, |
|
December 31, |
|
|
2018 |
|
2017 |
ASSETS |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
|
$ |
325,795 |
|
|
$ |
232,019 |
|
Accounts receivable |
|
13,545 |
|
|
10,753 |
|
Deferred commissions, current portion |
|
1,702 |
|
|
— |
|
Prepaid expenses and other current assets |
|
9,617 |
|
|
5,776 |
|
Total current assets |
|
350,659 |
|
|
248,548 |
|
Property and equipment, net |
|
33,514 |
|
|
32,871 |
|
Deferred commissions, non-current portion |
|
4,640 |
|
|
— |
|
Intangible assets, net |
|
72,598 |
|
|
7,377 |
|
Goodwill |
|
111,511 |
|
|
11,583 |
|
Other non-current assets |
|
1,528 |
|
|
934 |
|
TOTAL
ASSETS |
|
$ |
574,450 |
|
|
$ |
301,313 |
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
|
$ |
10,993 |
|
|
$ |
7,448 |
|
Accrued expenses and other liabilities |
|
17,443 |
|
|
13,099 |
|
Deferred revenue, current portion |
|
7,241 |
|
|
6,318 |
|
Other current liabilities |
|
832 |
|
|
1,828 |
|
Total current liabilities |
|
36,509 |
|
|
28,693 |
|
Convertible senior notes, net |
|
231,549 |
|
|
— |
|
Deferred revenue, non-current portion |
|
1,451 |
|
|
3,201 |
|
Deferred rent, non-current portion |
|
2,256 |
|
|
1,966 |
|
Financing obligation on leases, non-current portion |
|
14,634 |
|
|
14,932 |
|
Other non-current liabilities |
|
667 |
|
|
585 |
|
Total liabilities |
|
287,066 |
|
|
49,377 |
|
Stockholders' equity: |
|
|
|
|
Class A common stock, par value of $0.000004 per share;
1,000,000,000 shares authorized, 44,033,244 shares issued and
outstanding as of June 30, 2018; 1,000,000,000 shares authorized,
43,041,405 shares issued and outstanding as of December 31,
2017 |
|
1 |
|
|
1 |
|
Class B common stock, par value of $0.000004 per share;
100,000,000 shares authorized, 3,664,536 shares issued and
outstanding as of June 30, 2018; 100,000,000 shares authorized,
3,901,966 shares issued and outstanding as of December 31,
2017 |
|
— |
|
|
— |
|
Additional paid-in capital |
|
504,506 |
|
|
454,196 |
|
Accumulated other comprehensive loss |
|
(230 |
) |
|
(108 |
) |
Accumulated deficit |
|
(216,893 |
) |
|
(202,153 |
) |
Total stockholders' equity |
|
287,384 |
|
|
251,936 |
|
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
$ |
574,450 |
|
|
$ |
301,313 |
|
MINDBODY,
INC.Condensed Consolidated Statements of
Operations(in thousands, except per share
data)(Unaudited) |
|
|
|
|
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Revenue(1) |
$ |
61,611 |
|
|
$ |
44,107 |
|
|
$ |
115,434 |
|
|
$ |
86,321 |
|
Cost of
revenue(2) |
19,417 |
|
|
12,738 |
|
|
34,838 |
|
|
24,757 |
|
Gross
profit |
42,194 |
|
|
31,369 |
|
|
80,596 |
|
|
61,564 |
|
Operating
expenses: |
|
|
|
|
|
|
|
Sales and marketing(2) |
24,781 |
|
|
17,362 |
|
|
42,886 |
|
|
33,696 |
|
Research and development(2) |
17,547 |
|
|
8,802 |
|
|
29,335 |
|
|
17,450 |
|
General and administrative(2) |
16,075 |
|
|
9,358 |
|
|
28,738 |
|
|
18,044 |
|
Total operating expenses |
58,403 |
|
|
35,522 |
|
|
100,959 |
|
|
69,190 |
|
Loss from
operations |
(16,209 |
) |
|
(4,153 |
) |
|
(20,363 |
) |
|
(7,626 |
) |
Interest
income |
436 |
|
|
227 |
|
|
1,099 |
|
|
324 |
|
Interest
expense |
(1,037 |
) |
|
(310 |
) |
|
(1,334 |
) |
|
(621 |
) |
Other
income (expense), net |
(3 |
) |
|
(21 |
) |
|
36 |
|
|
(101 |
) |
Loss before
provision for income taxes |
(16,813 |
) |
|
(4,257 |
) |
|
(20,562 |
) |
|
(8,024 |
) |
Income tax
provision (benefit) |
78 |
|
|
118 |
|
|
(1,980 |
) |
|
260 |
|
Net
loss |
$ |
(16,891 |
) |
|
$ |
(4,375 |
) |
|
$ |
(18,582 |
) |
|
$ |
(8,284 |
) |
Net loss
per share, basic and diluted |
$ |
(0.36 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.39 |
) |
|
$ |
(0.20 |
) |
Weighted-average shares used to compute net loss per share, basic
and diluted |
|
47,552 |
|
|
|
43,147 |
|
|
|
47,330 |
|
|
|
41,958 |
|
|
|
|
|
|
|
|
|
(1) Total
revenue by category is presented below: |
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Revenue: |
|
|
|
|
|
|
|
Subscription and services |
$ |
38,540 |
|
|
$ |
25,992 |
|
|
$ |
71,283 |
|
|
$ |
50,945 |
|
Payments |
22,266 |
|
|
17,619 |
|
|
42,495 |
|
|
34,369 |
|
Product and
other |
805 |
|
|
496 |
|
|
1,656 |
|
|
1,007 |
|
Total revenue |
$ |
61,611 |
|
|
$ |
44,107 |
|
|
$ |
115,434 |
|
|
$ |
86,321 |
|
|
|
|
|
|
|
|
|
(2) Stock-based compensation expense included above was as
follows: |
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Cost of
revenue |
$ |
658 |
|
|
$ |
366 |
|
|
$ |
1,082 |
|
|
$ |
627 |
|
Sales and
marketing |
2,241 |
|
|
671 |
|
|
3,385 |
|
|
1,177 |
|
Research
and development |
2,048 |
|
|
980 |
|
|
3,360 |
|
|
1,507 |
|
General and
administrative |
2,455 |
|
|
1,496 |
|
|
4,391 |
|
|
2,699 |
|
Total stock-based compensation expense |
$ |
7,402 |
|
|
$ |
3,513 |
|
|
$ |
12,218 |
|
|
$ |
6,010 |
|
MINDBODY,
INC.Condensed Consolidated Statements of Cash
Flows(in thousands)(Unaudited) |
|
|
|
Six Months Ended June
30, |
2018 |
|
2017 |
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
Net loss |
$ |
(18,582 |
) |
|
$ |
(8,284 |
) |
Adjustments to reconcile net loss to net cash provided by (used in)
operating activities: |
|
|
|
Stock-based compensation expense |
12,218 |
|
|
6,010 |
|
Depreciation and amortization |
7,955 |
|
|
4,399 |
|
Amortization of deferred sales commission costs |
464 |
|
|
— |
|
Amortization of debt discount and issuance costs |
682 |
|
|
— |
|
Partial release of valuation allowance due to
acquisition |
(2,133 |
) |
|
— |
|
Other |
(6 |
) |
|
(6 |
) |
Changes in operating assets and liabilities net of effects of
acquisitions: |
|
|
|
Accounts receivable |
(586 |
) |
|
(100 |
) |
Deferred commissions |
(5,943 |
) |
|
— |
|
Prepaid expenses and other assets |
(1,733 |
) |
|
(1,073 |
) |
Accounts payable |
(2,447 |
) |
|
695 |
|
Accrued expenses and other liabilities |
3,903 |
|
|
1,270 |
|
Deferred revenue |
754 |
|
|
1,009 |
|
Deferred rent |
334 |
|
|
247 |
|
Net cash provided by (used in) operating activities |
(5,120 |
) |
|
4,167 |
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
Purchase of property and equipment |
(3,980 |
) |
|
(3,707 |
) |
Additions to internally developed software |
(1,339 |
) |
|
(237 |
) |
Acquisition of business, net of cash acquired |
(151,765 |
) |
|
(1,450 |
) |
Net cash used in investing activities |
(157,084 |
) |
|
(5,394 |
) |
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
Proceeds from issuance of convertible senior notes, net of issuance
costs |
300,902 |
|
|
— |
|
Purchase of capped calls related to issuance of convertible senior
notes |
(36,422 |
) |
|
— |
|
Net proceeds from follow-on public offering |
— |
|
|
134,528 |
|
Proceeds from exercise of equity awards |
4,839 |
|
|
4,637 |
|
Proceeds from employee stock purchase plan |
2,006 |
|
|
1,510 |
|
Payment related to shares withheld for taxes |
(3,753 |
) |
|
(1,461 |
) |
Repayment of Booker long term debt |
(10,008 |
) |
|
— |
|
Repayment on financing and capital lease obligations |
(253 |
) |
|
(211 |
) |
Payment of financing obligation related to Lymber and HealCode
acquisitions |
(1,250 |
) |
|
— |
|
Other |
— |
|
|
(33 |
) |
Net cash provided by financing activities |
256,061 |
|
|
138,970 |
|
Effect of exchange rate changes on cash and cash equivalents |
(81 |
) |
|
185 |
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
93,776 |
|
|
137,928 |
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
232,019 |
|
|
85,864 |
|
CASH AND CASH EQUIVALENTS, END OF PERIOD |
$ |
325,795 |
|
|
$ |
223,792 |
|
Reconciliation of Adjusted EBITDA: |
|
|
|
|
|
|
|
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
|
|
|
|
|
|
|
(in thousands) |
Net
loss |
$ |
(16,891 |
) |
|
$ |
(4,375 |
) |
|
$ |
(18,582 |
) |
|
$ |
(8,284 |
) |
Stock-based compensation expense |
7,402 |
|
|
3,513 |
|
|
12,218 |
|
|
6,010 |
|
Depreciation and amortization |
5,308 |
|
|
2,309 |
|
|
7,955 |
|
|
4,399 |
|
Acquisition-related expenses |
2,976 |
|
|
— |
|
|
4,288 |
|
|
— |
|
Income tax provision (benefit) |
78 |
|
|
118 |
|
|
(1,980 |
) |
|
260 |
|
Other (income) expense, net |
604 |
|
|
104 |
|
|
199 |
|
|
398 |
|
Adjusted
EBITDA |
$ |
(523 |
) |
|
$ |
1,669 |
|
|
$ |
4,098 |
|
|
$ |
2,783 |
|
|
|
|
|
|
|
|
|
Reconciliation of non-GAAP net loss: |
|
|
|
|
|
|
|
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
|
|
|
|
|
|
|
(in thousands) |
GAAP net
loss attributable to common stockholders |
$ |
(16,891 |
) |
|
$ |
(4,375 |
) |
|
$ |
(18,582 |
) |
|
$ |
(8,284 |
) |
Stock-based compensation expense |
7,402 |
|
|
3,513 |
|
|
12,218 |
|
|
6,010 |
|
Amortization of acquired intangible assets |
2,970 |
|
|
407 |
|
|
3,516 |
|
|
581 |
|
Acquisition-related expenses |
2,976 |
|
|
— |
|
|
4,288 |
|
|
— |
|
Amortization of debt discount and issuance costs |
682 |
|
|
— |
|
|
682 |
|
|
— |
|
Partial release of valuation allowance due to
acquisition |
— |
|
|
— |
|
|
(2,133 |
) |
|
— |
|
Non-GAAP
net loss |
$ |
(2,861 |
) |
|
$ |
(455 |
) |
|
$ |
(11 |
) |
|
$ |
(1,693 |
) |
|
|
|
|
|
|
|
|
Reconciliation of non-GAAP net loss per
share: |
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
GAAP net
loss per share, basic and diluted: |
$ |
(0.36 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.39 |
) |
|
$ |
(0.20 |
) |
Non-GAAP adjustments to net loss per share |
0.30 |
|
|
0.09 |
|
|
0.39 |
|
|
0.16 |
|
Non-GAAP adjustments to weighted-average shares used to
compute net income (loss) per share |
— |
|
|
— |
|
|
— |
|
|
— |
|
Non-GAAP
net loss per share |
$ |
(0.06 |
) |
|
$ |
(0.01 |
) |
|
$ |
— |
|
|
$ |
(0.04 |
) |
|
|
|
|
|
|
|
|
Reconciliation of non-GAAP diluted weighted-average
shares: |
|
Three Months Ended June
30, |
|
Six Months Ended June
30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
|
|
|
|
|
|
|
(in thousands) |
GAAP
weighted-average shares used to compute net loss per share, basic
and diluted |
47,552 |
|
|
43,147 |
|
|
47,330 |
|
|
41,958 |
|
Potentially
dilutive shares |
— |
|
|
— |
|
|
— |
|
|
— |
|
Non-GAAP
diluted weighted-average shares used to compute non-GAAP net loss
per share |
47,552 |
|
|
43,147 |
|
|
47,330 |
|
|
41,958 |
|
Contact:
Investor Relations:Nicole
GundersonIR@mindbodyonline.com 888-782-7155
Media Contact:Jennifer
Saxonjennifer.saxon@mindbodyonline.com805-419-2839
MINDBODY, INC. (NASDAQ:MB)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
MINDBODY, INC. (NASDAQ:MB)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025